PI

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal that publishes authoritative reviews and research papers on experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry, including a special section dedicated to psychedelics research. The journal does not publish work on biological extracts unless the pharmacologically active molecular substrate and/or specific receptor binding properties are elucidated, and bibliometric analysis studies are not considered.

Looking to publish in Progress in Neuro-Psychopharmacology and Biological Psychiatry? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Clinical Neurology, Neurosciences, Pharmacology & Pharmacy, Psychiatry
Impact Factor 3.9
Quartile Q1
Open Access Type Hybrid
ISSN 0278-5846
eISSN 1878-4216
Invitation Only No
Cost Range USD 4520 APC for open access articles; no open access publication fee for subscription publication.

Submission Instructions

Progress in Neuro-Psychopharmacology and Biological Psychiatry accepts the following article types. Click on an article type to view submission instructions.

Original Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract A concise and factual abstract is required. Abstract must not exceed 250 words.
Manuscript Manuscript must be divided into clearly defined and numbered sections, with the abstract excluded from section numbering. Manuscript must include 1 to 7 English keywords, 3 to 5 highlights submitted as a separate editable file, a generative AI declaration section before the references if applicable, and acknowledgements in a separate section before the references.
References References must use an author-date citation style. Reference list must be arranged alphabetically and then chronologically if needed, with in-text citations using author name and year and three or more authors shortened to first author plus et al.
Figures & Tables Tables must be submitted as editable text, while figures and other artwork must be uploaded as separate files along with the manuscript. All tables and figures must be cited in the text, numbered in order of appearance, and accompanied by captions.
Reformat to Progress in Neuro-Psychopharmacology and Biological Psychiatry using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract A concise, factual abstract is required. Abstract must not exceed 250 words.
Manuscript Manuscript must be divided into clearly defined and numbered sections, with the abstract excluded from section numbering. Submission must include 1 to 7 English keywords, 3 to 5 highlights submitted as a separate editable file, a declarations section including generative AI use before the references, acknowledgements before the reference list, and CRediT author contribution roles.
References References must use an author-date citation style. References must be listed alphabetically and then chronologically if needed, use author-year in-text citations, include standard bibliographic details, and abbreviate journal names according to the List of Title Word Abbreviations.
Figures & Tables Tables must be submitted as editable text, while figures and other artwork must be supplied as separate files along with the manuscript. All tables and figures must be cited in the text, numbered in order of appearance, and provided with captions.
Reformat to Progress in Neuro-Psychopharmacology and Biological Psychiatry using Livewrite Premium

Registered Reports

Cover Letter Cover Letter requirements are not specified.
Abstract A concise and factual abstract is required. Abstract must not exceed 250 words.
Manuscript Manuscript must be divided into clearly defined and numbered sections. Manuscript must include 1 to 7 English keywords, 3 to 5 highlights submitted as a separate editable file, and a generative AI declaration in a new section before the references if such tools were used.
References References must use an author-date style with the reference list arranged alphabetically and then chronologically if necessary.
Figures & Tables Tables must be submitted as editable text, and figures and other artwork must be supplied as separate files along with the manuscript. Tables must be cited in the text, numbered consecutively, and include captions, and all artwork must be cited in the text, numbered in order, and accompanied by captions.
Reformat to Progress in Neuro-Psychopharmacology and Biological Psychiatry using Livewrite Premium

Registered Report Stage I

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must not exceed 250 words.
Manuscript Manuscript must be divided into clearly defined and numbered sections. Manuscript must include 1 to 7 English keywords, 3 to 5 article highlights submitted as a separate editable file, a generative AI declaration section before the references if applicable, and acknowledgements in a separate section directly before the references.
References References must use an author-date citation style. Reference list must be arranged alphabetically and then chronologically if necessary, with in-text citations using author name and year and journal names abbreviated according to the List of Title Word Abbreviations.
Figures & Tables Tables must be included as editable text and figures must be supplied as separate files along with the manuscript. Tables must be cited in the text, numbered consecutively, and include captions, and all artwork must be cited in the text and accompanied by captions.
Reformat to Progress in Neuro-Psychopharmacology and Biological Psychiatry using Livewrite Premium

Registered Report Stage Ii

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must not exceed 250 words.
Manuscript Manuscript must be divided into clearly defined and numbered sections. Manuscript must include 1 to 7 English keywords, 3 to 5 highlights submitted as a separate editable file, a generative AI declaration in a new section before the references if applicable, acknowledgements in a separate section before the references, and CRediT author contribution roles.
References References must use an author-date citation system with the reference list arranged alphabetically and then chronologically if needed.
Figures & Tables Figures must be uploaded as separate files, while tables must be submitted as editable text. Tables must be cited in the text, numbered consecutively, and include captions, and all artwork must be cited in the text, numbered in order, and accompanied by captions.
Reformat to Progress in Neuro-Psychopharmacology and Biological Psychiatry using Livewrite Premium

Recent Publications

Polyamine stress response in schizophrenia: A translational framework beyond monoamine-centered models

Tayfun Uzbay

10.1016/j.pnpbp.2026.111894
View Publication

Sleep and psychosis: An integrative review of conceptual and neurophysiological associations

Zhiyu Cui, Linlin Fan

10.1016/j.pnpbp.2026.111895
View Publication

Association between kynurenine pathway metabolites and psychotropic medications in bipolar disorder: An exploratory study in the FACE-BD cohort

Bruno Etain, Vincent Hennion, Valérie Autier, Sophie Raynal, Ophélia Godin, Bruno Aouizerate, Raoul Belzeaux, Philippe Courtet, Caroline Dubertret, Antoine Lefrere, Emilie Olié, Mircea Polosan, Paul Roux, Raymund Schwan, Samalin Ludovic, Marion Leboyer, Cynthia Marie-Claire, Sophie Gil

10.1016/j.pnpbp.2026.111891
View Publication

Brain connectivity mediates the association between childhood maltreatment and personality in young adults

Yajing Pang, Zhiyuan Zhang, Xinlei Wang, Jianyue Pang, Shanshan Zhao, Lingyun Gao, Rui Zhang, Zhihui Li, Jiaojian Wang

10.1016/j.pnpbp.2026.111897
View Publication

Multimodal neuroimaging changes and their behavioral, genetic, and neurotransmitter correlates in electroconvulsive therapy for major depressive disorder

Ruifeng Shi, Yikai Dou, Ying He, Cui Yuan, Yaoxia Liu, Xiaoxia Wang, Dong Yang, Daotao Lan, Lu Yuan, Yihan Su, Zuxing Wang

10.1016/j.pnpbp.2026.111890
View Publication

Frequently asked questions

How long does it take to publish?

38 days from submission to first decision; 91 days from submission to decision after review; 149 days from submission to acceptance; 2 days from acceptance to online publication.

Reformat to Progress in Neuro-Psychopharmacology and Biological Psychiatry using Livewrite Premium

What are the publication costs?

USD 4520 APC excluding taxes for open access articles; no open access publication fee for subscription publication.

Reformat to Progress in Neuro-Psychopharmacology and Biological Psychiatry using Livewrite Premium

Research Topics

Neurotransmitter Receptor Influence on Behavior Neuroscience and Neuropharmacology Research Tryptophan and brain disorders Schizophrenia research and treatment Stress Responses and Cortisol Bipolar Disorder and Treatment Treatment of Major Depression Functional Brain Connectivity Studies Receptor Mechanisms and Signaling Neuroendocrine regulation and behavior Memory and Neural Mechanisms Human auditory perception and evaluation Diverse Scientific and Economic Studies Obsessive-Compulsive Spectrum Disorders Electroconvulsive Therapy Studies Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Attention Deficit Hyperactivity Disorder Neural and Behavioral Psychology Studies Neuropeptides and Animal Physiology Autism Spectrum Disorder Research Cannabis and Cannabinoid Research Educational Robotics and Engineering Nicotinic Acetylcholine Receptors Study Neuroinflammation and Neurodegeneration Mechanisms Sleep and Wakefulness Research

Related Journals

TL
The Lancet Oncology Elsevier BV
JO
Journal of Reproductive Immunology Elsevier BV
MM
Molecular Metabolism Elsevier BV
IT
IEEE Transactions on Cognitive and Developmental Systems Institute of Electrical and Electronics Engineers
JO
Journal of Epidemiology and Global Health Elsevier BV
CR
Cell Reports Medicine Elsevier BV